Healthcare Compliance Intelligence Hub
Real-time regulatory updates from DEA, DOJ, FDA, CMS, and all 50 state medical boards — curated and analyzed by AI, reviewed by compliance experts. The only source you need to stay ahead of healthcare regulation changes.
Regulatory Intelligence Feed
196 articles published · Page 1 of 14
Michigan Medical Board Enforcement Trends: Focus on Telehealth and Medspa Compliance
The Michigan Board of Medicine is actively monitoring and enforcing regulations related to telehealth and medspa operations, with disciplinary actions often stemming from issues like unprofessional conduct, scope of practice violations, and inadequate supervision. Healthcare providers and businesses operating in Michigan, particularly those utilizing telehealth or offering medspa services, must ensure strict adherence to state licensing laws, administrative rules, and professional standards to mitigate enforcement risks.
DEA Proposes New Telehealth Prescribing Rules for Buprenorphine and Other Controlled Substances
The DEA has issued proposed rules outlining requirements for prescribing controlled medications via telehealth, including buprenorphine for opioid use disorder. These rules aim to establish a balance between expanding access to care and preventing diversion, primarily by requiring an in-person medical evaluation for initial prescriptions of Schedule II and certain Schedule III-V controlled substances, with specific exceptions for buprenorphine.
Kentucky's Corporate Practice of Medicine Doctrine: Implications for Telehealth and Medspa Business Structures
Kentucky maintains a Corporate Practice of Medicine (CPOM) doctrine that generally prohibits corporations from employing physicians or controlling medical decision-making. This framework significantly impacts the legal structuring of telehealth providers and medspas operating in the state, requiring careful adherence to exceptions and compliant management service organization (MSO) models.
DOJ Intensifies Enforcement Against Telehealth Controlled Substance Prescribing Violations
The Department of Justice (DOJ) has significantly increased its focus on prosecuting telehealth companies and practitioners involved in illegal prescribing and distribution of controlled substances. This trend underscores the critical importance of strict adherence to federal and state prescribing regulations, particularly regarding the Ryan Haight Act and legitimate medical purpose requirements for telehealth encounters.
Navigating DEA Registration for Telehealth Providers Prescribing Controlled Substances Across State Lines
This article clarifies the complex DEA registration requirements for telehealth providers who prescribe controlled substances, particularly when crossing state lines. It addresses the implications of the Ryan Haight Act, the expiration of COVID-19 PHE waivers, and the DEA's proposed rules for prescribing controlled medications via telemedicine.
Navigating Telehealth for Chiropractic Care: State Board Regulations and Remote Patient Management
State chiropractic boards are increasingly issuing guidance and regulations on the use of telehealth for chiropractic care, including initial consultations, follow-up visits, and remote patient management. These regulations often define what services are permissible via telehealth, require patient consent, and specify documentation standards, impacting how chiropractors can integrate virtual care into their practices.
Iowa's Strict Corporate Practice of Medicine Doctrine: Implications for Telehealth and Medspa Operations
Iowa maintains a strict Corporate Practice of Medicine (CPOM) doctrine, prohibiting corporations and non-licensed entities from employing physicians or controlling medical decision-making. This significantly impacts the permissible business structures for telehealth providers, medspas, and other healthcare businesses operating in the state, requiring careful adherence to professional corporation models or management service organization (MSO) arrangements that respect professional independence.
Navigating Corporate Practice of Medicine Restrictions for DTC Telehealth Weight Loss Brands
Direct-to-consumer (DTC) telehealth weight loss brands face significant compliance challenges in states with strict Corporate Practice of Medicine (CPOM) doctrines. These laws prohibit corporations from employing physicians or controlling medical practices, requiring careful structuring to ensure physician independence and prevent fee-splitting.
District of Columbia Telehealth: Establishing a Valid Provider-Patient Relationship and Prescribing Requirements
The District of Columbia has specific regulations governing the establishment of a valid provider-patient relationship via telehealth, which is a prerequisite for prescribing. Practitioners must adhere to these standards, including a real-time, interactive audio-visual examination, to ensure compliance and avoid potential regulatory violations. Understanding these rules is crucial for any healthcare business operating or expanding telehealth services in DC.
CMS Expands Telehealth Services and Provider Eligibility Under Medicare
The Centers for Medicare & Medicaid Services (CMS) has continued to expand the list of services eligible for Medicare reimbursement when furnished via telehealth, along with broadening the types of providers who can deliver these services. These updates reflect a sustained commitment to integrating telehealth into the permanent healthcare landscape, moving beyond pandemic-era flexibilities.
Navigating Corporate Practice of Medicine (CPOM) for DTC Telehealth Weight Loss Brands
Direct-to-Consumer (DTC) telehealth weight loss brands face significant compliance challenges in states with strict Corporate Practice of Medicine (CPOM) doctrines. These laws prohibit corporations from employing physicians or dictating medical decisions, necessitating careful structuring to avoid illegal fee-splitting and ensure physician independence.
DEA Registration and Telehealth Prescribing of Controlled Substances Across State Lines: Navigating Post-PHE Regulations
This article clarifies the evolving DEA regulations regarding the prescribing of controlled substances via telehealth, particularly for providers operating across state lines. It addresses the impact of the Ryan Haight Act, the temporary waivers during the COVID-19 Public Health Emergency, and the DEA's subsequent proposed rules for a permanent telehealth prescribing framework.
CMS Requirements for Telehealth Provider Credentialing and Medicare Enrollment
The Centers for Medicare & Medicaid Services (CMS) has specific requirements for healthcare providers to credential and enroll in Medicare, which are critical for billing telehealth services. Understanding these rules, including temporary waivers and permanent flexibilities, is essential for compliant telehealth operations and reimbursement.
Navigating Multi-State Practice: An Overview of Telehealth Licensing Compacts and Their Impact
Interstate licensure compacts like IMLC, PSYPACT, and the ASWB Social Work Compact are streamlining multi-state practice for various healthcare professionals, enabling telehealth expansion while maintaining regulatory oversight. These compacts offer a pathway for licensed providers to practice across state lines without obtaining full, individual licenses in each participating jurisdiction.
New Jersey Pharmacy Board Clarifies Telehealth Prescribing, Compounding, and Fulfillment Regulations
The New Jersey State Board of Pharmacy has established clear regulations governing the dispensing, compounding, and fulfillment of prescriptions originating from telehealth encounters. These rules emphasize patient safety, proper prescription transmission, and adherence to compounding standards, directly impacting telehealth providers operating within or serving New Jersey residents.
In-Depth Compliance Resources
Comprehensive guides, checklists, and templates to help you navigate healthcare compliance — from CPOM structuring to GFE requirements and medical director agreements.
The Complete Guide to Good Faith Exams
Everything you need to know about GFE requirements, best practices, and state-specific regulations.
Read guideCPOM Laws: A State-by-State Analysis
Comprehensive breakdown of Corporate Practice of Medicine laws across all 50 states.
Read guideHealthcare Compliance Checklist 2026
The definitive checklist for launching and maintaining compliant telehealth and in-person healthcare operations.
Read guidePC-MSO Formation Guide
Step-by-step guide to structuring Professional Corporations and Management Services Organizations.
Read guideMedical Director Requirements by State
State-by-state requirements for medical director oversight in telehealth, medspas, IV therapy clinics, and other healthcare operations.
Read guideGLP-1 Prescribing Compliance Guide
Regulatory requirements for GLP-1 weight loss medication prescribing via telehealth.
Read guideCollaborative Practice Agreement Templates
State-specific CPA templates and guidance for physician-NP collaborative arrangements.
Read guideStay Ahead of Every Regulatory Change
Our AI-powered intelligence engine monitors DEA, DOJ, FDA, CMS, and all 50 state medical boards so you never miss a compliance update that affects your business.